Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The European subsidiary of Mitsubishi Tanabe Pharma, Mitsubishi Pharma Europe (MPE), has selected NextPharma Technologies Holding for the launch of BindRen in Europe.
Subscribe to our email newsletter
As a fully-serviced outsourcing partner, NextPharma will offer primary and secondary packaging solutions within the European territory.
MPE vice president Toshiaki Mikuni said, "We needed a partner with a significant European presence and we were also impressed by the packaging solutions available at NextPharma’s state-of-the-art, solids facility in Germany."
Launched already in Germany and Austria, BindRen is scheduled to be introduced in other countries shortly.
With a generic name as colestilan, the orally available non-absorbed anion exchange resin has been developed to treathyperphosphataemia in adult patients with Chronic Kidney Disease (CKD) Stage 5 receiving haemodialysis or peritoneal dialysis.